<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Beesetti S</submitter><funding>National Institute of Allergy and Infectious Diseases</funding><funding>NIAID NIH HHS</funding><funding>Burroughs Wellcome Fund</funding><funding>American Lebanese Syrian Associated Charities</funding><funding>National Institutes of Health</funding><funding>National Institute of General Medical Sciences</funding><funding>St. Jude Children&amp;amp;apos;s Research Hospital</funding><funding>NIGMS NIH HHS</funding><pagination>166453</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9844820</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>1868(9)</volume><pubmed_abstract>Fanconi anemia (FA) is the most common inherited bone marrow failure syndrome. The FA proteins have functions in genome maintenance and in the cytoplasmic process of selective autophagy, beyond their canonical roles of repairing DNA interstrand cross-links. FA core complex proteins FANCC, FANCF, FANCL, FANCA, FANCD2, BRCA1 and BRCA2, which previously had no known direct functions outside the nucleus, have recently been implicated in mitophagy. Although mutations in FANCL account for only a very small number of cases in FA families, it plays a key role in the FA pathophysiology and might drive carcinogenesis. Here, we demonstrate that FANCL protein is present in mitochondria in the control and Oligomycin and Antimycin (OA)-treated cells and its ubiquitin ligase activity is not required for </pubmed_abstract><journal>Biochimica et biophysica acta. Molecular basis of disease</journal><pubmed_title>FANCL supports Parkin-mediated mitophagy in a ubiquitin ligase-independent manner.</pubmed_title><pmcid>PMC9844820</pmcid><funding_grant_id>R01 GM132231</funding_grant_id><funding_grant_id>R21 AI142044</funding_grant_id><funding_grant_id>R01GM132231</funding_grant_id><pubmed_authors>Levine B</pubmed_authors><pubmed_authors>Sakurada SM</pubmed_authors><pubmed_authors>Pruett-Miller SM</pubmed_authors><pubmed_authors>Potts MB</pubmed_authors><pubmed_authors>Beesetti S</pubmed_authors><pubmed_authors>Sirasanagandla S</pubmed_authors><pubmed_authors>Sumpter R</pubmed_authors></additional><is_claimable>false</is_claimable><name>FANCL supports Parkin-mediated mitophagy in a ubiquitin ligase-independent manner.</name><description>Fanconi anemia (FA) is the most common inherited bone marrow failure syndrome. The FA proteins have functions in genome maintenance and in the cytoplasmic process of selective autophagy, beyond their canonical roles of repairing DNA interstrand cross-links. FA core complex proteins FANCC, FANCF, FANCL, FANCA, FANCD2, BRCA1 and BRCA2, which previously had no known direct functions outside the nucleus, have recently been implicated in mitophagy. Although mutations in FANCL account for only a very small number of cases in FA families, it plays a key role in the FA pathophysiology and might drive carcinogenesis. Here, we demonstrate that FANCL protein is present in mitochondria in the control and Oligomycin and Antimycin (OA)-treated cells and its ubiquitin ligase activity is not required for </description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2025-04-04T22:55:13.095Z</modification><creation>2025-04-04T22:55:13.095Z</creation></dates><accession>S-EPMC9844820</accession><cross_references><pubmed>35644338</pubmed><doi>10.1016/j.bbadis.2022.166453</doi></cross_references></HashMap>